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Chromosomal abnormalities are commonly found in bronchogenic carcinoma cells, but the molecular causes of chromosomal
instability (CIN) and their relationship to cigarette smoke has not been defined. Because the Fanconi anaemia (FA)/BRCA pathway is
essential for maintenance of chromosomal stability, we tested the hypothesis that cigarette smoke suppresses that activity of this
pathway. Here, we show that cigarette smoke condensate (CSC) inhibited translation of FANCD2 mRNA (but not FANCC or FANCG)
in normal airway epithelial cells and that this suppression of FANCD2 expression was sufficient to induce both genetic instability and
programmed cell death in the exposed cell population. Cigarette smoke condensate also suppressed FANCD2 function and induced
CIN in bronchogenic carcinoma cells, but these cells were resistant to CSC-induced apoptosis relative to normal airway epithelial
cells. We, therefore, suggest that CSC exerts pressure on airway epithelial cells that results in selection and emergence of genetically
unstable somatic mutant clones that may have lost the capacity to effectively execute an apoptotic programme. Carcinogen-mediated
suppression of FANCD2 gene expression provides a plausible molecular mechanism for CIN in bronchogenic carcinogenesis.
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Lung cancer is the most common malignancy in the world causing
over one million deaths per year (Kamangar et al, 2006). The major
causative factor is cigarette smoke, which is linked to greater than
90% of cases (Jemal et al, 2001). Lung cancers display high levels of
chromosomal instability (CIN) (Masuda and Takahashi, 2002), and
preliminary evidence suggests that cigarette smoke condensate
(CSC) may directly induce CIN (Luo et al, 2004). However, no
specific biochemical or genetic mechanisms for this have been
identified.
Potential carcinogenic effects of cigarette smoke can be
modelled in vitro by exposing airway epithelial cells to CSC. This
approach has been widely used to define biological responses to
CSC (Andreoli et al, 2003), and, in some instances, to define
specific categories of genetic damage induced by CSC (Albino et al,
2004; Luo et al, 2004). Few studies have clarified, however, the
effects of CSC on caretaker pathways that protect the genome
from environmental stressors. Because of the high incidence
of aerodigestive malignancies in the inherited chromosomal
instability disease Fanconi anaemia (FA), the universal presence
of CIN in FA cells and complex cytogenetic defects in neoplastic
FA cells, and the well-known biochemical role played by FA
proteins in stabilising the genome (Bagby and Alter, 2006), we
hypothesised that one or more of the chemicals in CSC might
suppress the function of the FA pathway in normal individuals and
destabilise the genome in exposed cells of the airway.
Fanconi anaemia is caused by biallelic (or X-chromosome-
linked) inactivation of 1 out of 13 FA genes (Bagby and Alter, 2006;
Dorsman et al, 2007; Smogorzewska et al, 2007), including BRCA2
(FANCD1). Eight of the gene products form a nuclear core complex
(FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, and
FANCM), a complex that must be completely intact for FANCD2 to
become monoubiquitinated. Therefore, to delineate the in vitro
effects of CSC on FA gene expression in human airway epithelial
cells, we measured formation of monoubiquitinated and non-
ubiquitinated FANCD2 after CSC treatment. Here, we show that
CSC suppressed translation of FANCD2 and that overexpression of
FANCD2 protected cells from the toxic effects of cigarette smoke.
The protective effects of FANCD2 were specific as CSC did not
substantially decrease expression of other FA proteins (FANCC
and FANCG) in airway epithelial cells and overexpression of these
same FA proteins did not alter CSC-induced toxicity. Fancc-
deficient cells, however, were hypersensitive to CSC demonstrating
that it is the monoubiquitinated form of FANCD2 that protects
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scells against CSC. Furthermore, FANCD2 suppression induced CIN
in exposed normal and neoplastic epithelial cells; however,
bronchogenic carcinoma cells were resistant to CSC-induced
toxicity.
MATERIALS AND METHODS
Cell culture and chemicals
Primary airway epithelial cells were prepared from human tracheas
obtained at Oregon Health & Science University (OHSU) using an
Institutional Review Board-approved protocol by incubation with
0.1% pronase solution (Sigma-Aldrich, St Louis, Missouri, USA)
and designated HIT1. A portion of the primary airway epithelial
cells was transformed by retroviral transduction of SV40 large T-
antigen (packaging line PA12/UL95 was derived from c2/UL95
provided by Dr Roger Cone at OHSU) and hTERT (packaging line
PG13/hTERT kindly provided by Dr Denise Galloway at Fred
Hutchinson Cancer Research Center) and designated HIT1-SVTEL.
Transformed and untransformed primary airway epithelial cells
displayed similar sensitivities to CSC (Figure 1A). HIT1-SVTEL
cells ectopically expressing FANCD2, FANCC, or FANCG were
derived by retroviral transduction and designated HIT1-SVTEL/
FANCD2, HIT1-SVTEL/FANCC, or HIT1-SVTEL/FANCG, respec-
tively. FANCD2 retrovirus was produced from a pMMP vector as
described previously (Garcia-Higuera et al, 2001). Retroviruses
containing FANCC or FANCG were produced from 293T cells
transfected with gag/pol, envelope, and MIEG3 plasmids contain-
ing FANCC or FANCG cDNA (all plasmids kindly provided by
Dr Qishen Pang at Cincinnati Children’s Hospital Medical Center).
Murine tracheal airway epithelial cells and/or murine embryonic
fibroblasts (MEFs) were prepared from wild-type, Fancd2-, and
Fancc-deficient mice (kindly provided by Drs Markus Grompe at
OHSU and Wade Clapp at Indiana University School of Medicine).
A portion of the murine airway epithelial cells was transformed
with SV40 (as described above). Murine embryonic fibroblasts
were prepared from day 14 to 16 embryos. Bronchogenic cancer
lines A549 and H292 were obtained from American Type Culture
Collection. The FANCD2-mutant human fibroblast line PD20 and
the isogenic FANCD2-complemented line PD20/D2 were obtained
from the OHSU FA Cell Repository and Markus Grompe. Airway
epithelial cells were grown in Dulbecco’s Modified Eagle Medium
(DMEM; Invitrogen, Carlsbad, CA, USA), whereas fibroblasts were
grown in Minimal Essential Medium-alpha (both with 10% fetal
bovine serum (FBS); Hyclone, Logan, UT, USA). Mitomycin C
(MMC), epoxomicin, and cycloheximide (all from Sigma-Aldrich)
were solubilised as per the manufacturer’s instructions. Chromo-
somal breakage assays were performed as described previously
(Pejovic et al, 2006).
Preparation of cigarette smoke condensate
Mainstream CSC was sampled to collect both gas-phase and
particle-phase constituents from the smoke generated from a
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Figure 1 Cigarette smoke condensate downregulates FANCD2. (A) Survival analyses of primary (HIT1) and SV40- and hTERT-transformed (HIT1-
SVTEL) human airway epithelial cells treated with indicated concentrations of CSC for 24h are shown. Data points are means±s.d. from three experiments
performed in triplicate. HIT1 and HIT1-SVTEL were not significantly different in their sensitivities to CSC (P¼0.9, regression analysis). (B) Immunoblot of
HIT1-SVTEL cells treated with indicated concentrations of CSC or MMC for 24h (FANCD2-L¼monoubiquitinated; FANCD2-S¼nonubiquitinated) is
shown. (C) Immunoblots of HIT1-SVTEL or BEAS2b (normal bronchial epithelial) cells treated with 0.2% CSC for indicated time intervals are shown. (D, E)
Immunoblots of HIT1-SVTEL cells treated with indicated concentrations of CSC for 24h are shown.
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smajor US brand of filtered, ‘full-flavour’ cigarette. Multiple
samples were collected and utilised over the course of the project.
For each, 20 cigarettes from a single pack were smoked according
to the ‘Massachusetts’ smoking protocol (successive 45ml puffs,
each puff 2s in duration, one puff every 30s, cigarette smoke to
within 23mm of the filter overwrap paper; described in Hammond
et al, 2006). As described elsewhere (Barsanti et al, 2007), the
smoke passed through (a) 50ml (70cm long) chamber to allow
particle coagulation; then (b) a jet orifice directed at the wall of a
20-ml glass vial (to collect particles). The flow was then directed to
two bubble impingers each containing 5ml of DMSO to collect gas-
phase constituents. After all 20 cigarettes were smoked, the DMSO
was used to wash the 50-ml chamber, then placed in a 20-ml vial. A
total of 5ml of additional DMSO was used to wash the impingers
then added to the 20-ml vial. The vial was then sonicated for 30s.
After 4h at room temperature in the dark, 6ml of the clear
supernatant was drawn off by pipette. Gentle volatilisation of an
aliquot of the supernatant allowed the gravimetric determination
of the total concentration of lower volatility constituents (e.g., tar)
giving B25mgml
 1. Each sample in DMSO was kept stored at 41C
until used for experiments.
Survival and apoptosis assays
Cells were treated with different concentrations of CSC solubilised
in DMSO for 8–24h. In additional experiments, cells were treated
with MMC for 24h. Survival was measured with the dye-exclusion
assay ViaCount (Guava Technologies, Hayward, CA, USA) and
apoptosis was measured by either Annexin V (BD Biosciences,
Bedford, MA, USA) or TUNEL staining (Guava Technologies). All
assays were run and analysed with the Guava PCA-96 micro-
cytometer.
Immunoblotting
Cells were treated with CSC (0.05–0.25% which represents the
amount of condensate extracted from roughly 1 to 5% of one
cigarette) or MMC (1 and 2.5mM) for 24h. Some were pretreated
with epoxomicin for 2h. Whole-cell lysates were prepared,
separated by SDS-PAGE, and immunoblotted as described else-
where (Pang et al, 2001). Primary antibodies used were mouse
monoclonal anti-FANCD2 (diluted 1:200; Santa Cruz, Santa Cruz,
CA, USA), rabbit polyclonal anti-b-actin (diluted 1:1000; Cell
Signaling Technology, Beverly, MA, USA), mouse monoclonal
anti-PCNA (1:2000; Cell Signaling Technology), rabbit polyclonals
anti-FANCC, and anti-FANCG (1:1000; OHSU FA Antibody
Project). Immunoblotting with anti-b-actin was performed on
different aliquots of the same original samples immunoblotted
with the different primary antibodies to confirm that total proteins
levels were similar. Approximate molecular weights of FANCD-S,
FANCD2-L, b-actin, PCNA, FANCC, and FANCG are 155, 162, 45,
36, 60, and 65kDa, respectively. Secondary antibodies (1:10000
dilution) were horseradish peroxidase-conjugated goat anti-mouse
or goat anti-rabbit antibodies (Bio-Rad, Hercules, CA, USA). For
FANCD2 half-life experiments, HIT1-SVTEL cells were treated
simultaneously with 0.2% CSC and 20mgml
 1 cycloheximide
(Sigma-Aldrich). Intensities of FANCD2 bands were determined by
densitometry.
RNA measurements
Total RNA was prepared from 5 10
6 cells using the RNeasy Mini
kit (Qiagen, Valencia, CA, USA). Complementary DNA synthesis
and real-time PCR were performed as described previously
(Pejovic et al, 2006). Predesigned primer and probe sets for
FANCD2 (Hs00696862_m1) and PCNA (Hs00945440_m1) were
purchased as Taqman Gene Expression Assays from Applied
Biosystems, and other primer/probe sets (Supplementary Table 1)
were described previously (Pejovic et al, 2006).
Protein synthesis experiments
HIT1-SVTEL cells were incubated in DMEM minus L-methionine
and L-cysteine (Invitrogen) plus 10% dialysed FBS (Hyclone) for
30min. For global protein synthesis experiments, cells were
incubated with CSC for 1–2h and then incubated with 50mCiml
 1
[
35S]-methionine/cysteine (PerkinElmer, Boston, MA, USA) for
30min. [
35S] incorporation was measured by liquid scintillation
counting. For measurements of FANCD2 synthesis, HIT1-SVTEL,
PD20, and PD20/FANCD2 cells were treated with either 0.2% CSC
or DMSO plus approximately 300mCiml
 1 [
35S]-methionine/
cysteine for 3h. Whole-cell lysates were prepared as described
above and then incubated consecutively with anti-FANCD2
monoclonal antibody and protein G-sepharose beads (Sigma-
Aldrich). Washed pellets were then loaded onto 4–15% gradient
acrylamide gels (Bio-Rad) and subjected to SDS-PAGE. FANCD2
was visualised by autoradiography. The intensities of FANCD2
bands were determined by densitometry.
Densitometry
The relative intensities of FANCD2 bands were measured with Bio-
Rad’s Gel Documentation System and analysed with Quantity One
software. The values of both FANCD2-L and FANCD2-S were
combined for each lane/sample and treated samples were
compared with controls.
Statistics
a-Values for ANOVA (analysis of variance), linear regression
analyses, and t-tests were 0.05. Analysis of variance test was two-
way. The two-tailed one-sample t-test compared the mean of
experimental results to the defined control value of 100%. Values
shown in all graphs represent the means±s.d.
RESULTS
To determine if CSC induced alterations in FA core complex
function, we quantified FANCD2 protein in human airway
epithelial cells at various times after exposure. Concentrations of
CSC (0.05–0.25%) used represented approximately 1–5% of the
yield from a single cigarette. The total amounts of FANCD2-S and
FANCD2-L were markedly reduced after treatment (Figure 1B).
However, both FANCD2-S and FANCD2-L were detectable,
indicating that the eight core complex proteins were all functional.
Maximal FANCD2 suppression occurred after 24h of CSC
exposure and occurred in a variety of airway epithelial cell lines
(Figure 1C). FANCD2 suppression was detectable at doses as low as
0.05% CSC and was maximal at 0.2% (Figure 1D). The response of
FANCD2 to CSC could not be attributed to any potential
crosslinking agent in CSC, because it differed in these cells from
the response induced by the crosslinking agent MMC. Mitomycin
C, as expected (Garcia-Higuera et al, 2001), caused an almost
complete conversion to FANCD2-L during the same treatment
period (Figure 1B). The doses of MMC used in Figure 1B were
approximately equitoxic to 0.05% CSC (Figure 1A and data not
shown), and, as shown in Figure 1D, the effect of 0.05% CSC on
FANCD2 expression was different from equitoxic doses of MMC
(Figure 1B). We ruled out the possibility that CSC-induced
FANCD2 reduction was due to mitotic arrest or cell growth
inhibition by measuring both the level of the proliferation marker
PCNA and the effects of CSC on cell-cycle distribution, neither of
which changed at the 24h time point (Figure 1C and data not
shown). Furthermore, we examined whether CSC downregulated
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sexpression of other FA pathway members, although this seemed
unlikely because FANCD2-L was still present in CSC-treated
airway epithelial cells. As expected, neither FANCC nor FANCG
expression was substantially downregulated after CSC treatment
(Figure 1E).
Fanconi anaemia cells are so characteristically hypersensitive to
crosslinking agents such as MMC that this forms the basis of the
most widely utilised diagnostic test (Bagby and Alter, 2006). In
nonneoplastic cells, the hypersensitivity is found both in survival
and chromosomal breakage assays. To determine whether CSC-
induced FANCD2 suppression was sufficient to induce the FA
phenotype, we asked whether CSC sensitised cells to MMC.
Treatment with CSC for 24h significantly increased the sensitivity
of airway epithelial cells to MMC in a survival assay (Figure 2A).
FANCD2 suppression was sufficient to account for MMC
hypersensitivity, because ectopic expression of FANCD2 protected
cells from becoming MMC hypersensitive in response to CSC
(Figures 2B and C).
Toxicity of CSC is well documented (Andreoli et al, 2003).
Because FA progenitor cells are hypersensitive to apoptotic cues
(Lensch et al, 1999), we suspected that suppression of FANCD2
might be one cause of CSC-induced cell death. Indeed, CSC was
toxic to airway epithelial cells, with an EC50 of approximately 0.3%
vol/vol (Figure 2D) and a significant proportion of cell death was
due to induction of apoptosis, as measured by Annexin V staining
(Figure 2E). Overexpression of FANCD2 in airway epithelial cells
increased the EC50 of CSC to 0.5% vol/vol (Figure 2D) and
decreased the percentage of apoptotic cells after CSC treatment
compared with HIT1-SVTEL cells (Figure 2E), confirming that
FANCD2 suppression contributed in part to CSC-induced toxicity.
To demonstrate that protective effects of FANCD2 were specific
and not simply due to a consequence of overexpressing any
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Figure 2 Decreased FANCD2 sensitises cells to CSC. (A) Survival analyses of HIT1-SVTEL cells treated sequentially with CSC and MMC for 24h each
(means±s.d. from three experiments performed in triplicate) are shown. Cigarette smoke condensate significantly sensitised HIT1-SVTEL cells to MMC at
all concentrations (Po0.0001, ANOVA). (B) Immunoblot of HIT1-SVTEL cells with or without transduced FANCD2 (HIT1-SVTEL/FANCD2¼HIT1-SVTEL
transduced with FANCD2) treated with 0.2% CSC for indicated time intervals are shown. (C) Survival analyses of HIT1-SVTEL/FANCD2 cells treated
sequentially with CSC and MMC for 24h each (means±s.d. from three experiments performed in triplicate) are shown. Cigarette smoke condensate did
not sensitise HIT1-SVTEL/FANCD2 cells to MMC (P¼0.9, ANOVA). (D) Survival analyses of HIT1-SVTEL and HIT1-SVTEL/FANCD2 cells treated with
indicated concentrations of CSC for 24h are shown. Data points are means±s.d. from three experiments performed in triplicate. HIT1-SVTEL/FANCD2
cells were more resistant than HIT1-SVTEL cells to CSC (Po0.0001, regression analysis). (E) Apoptosis measurements of HIT1-SVTEL and HIT1-SVTEL/
FANCD2 cells treated with indicated concentrations CSC for 24h are shown. Values are means±s.d. of triplicate samples in one of the three similar
experiments.
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sFA/BRCA pathway member, we derived HIT1-SVTEL cells
ectopically expressing either FANCC or FANCG (HIT1-SVTEL/
FANCC or HIT1-SVTEL/FANCG, respectively; Figure 3A). In
contrast to the protective effects of FANCD2, ectopic expression
of neither FANCC nor FANCG changed the sensitivity of airway
epithelial cells to CSC (Figure 3B).
Using a genetic model to confirm that reduction/loss of
FANCD2 sensitises cells to CSC, we tested susceptibility of airway
epithelial cells and embryonic fibroblasts from Fancd2-deficient
mice. As expected, Fancd2-deficient cells were hypersensitive to
CSC in both cell survival (Figure 4A) and breakage assays
(Figure 4B). In the breakage assays, low levels of CSC (0.05 and
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Figure 4 Fancd2- and Fancc-deficient cells are hypersensitive to CSC. (A) Survival analyses of primary wild-type and Fancd2-deficient murine airway
epithelial cells treated with indicated concentrations of CSC for 24h are shown. Values are means±s.d. of triplicate samples in one of the three similar
experiments. Fancd2-deficient airway epithelial cells were significantly more sensitive to CSC than wild type (Po0.05, regression analysis). (B) Chromosomal
breakage analyses of wild-type and Fancd2-deficient MEFs treated with indicated concentrations of CSC for 24h are shown. Values represent means±s.d.
from three independent cell lines. (C) Survival analyses of wild-type and Fancc-deficient transformed murine airway epithelial cells treated with indicated
concentrations of CSC for 24h are shown. Values are means±s.d. from three independent experiments performed in triplicate.
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s0.1%) induced chromosomal breaks in 40–45% of Fancd2-
deficient cells, but in only 5% of wild-type cells (Figure 4B).
Fancc-deficient airway epithelial cells were also hypersensitive to
CSC (Figure 4C), demonstrating that the presence of nonubiqui-
tinated FANCD2 was not sufficient to provide protective effects
against CSC-induced toxicity.
Reduced FANCD2 did not correlate with reduced proliferation
or growth of treated cells (Figure 1C). To determine general
mechanisms by which FANCD2 expression was suppressed, we
measured FANCD2 and PCNA mRNA levels after CSC treatment
using quantitative real-time PCR (Figure 5A). After 8–24h of
treatment, FANCD2 RNA declined slightly; a decline that could not
account for the roughly 90% decrease in FANCD2 protein by 24h
(Figures 1B and C). Cigarette smoke condensate exposure did not
significantly alter transcripts of 27 other FA or DNA repair genes
(Supplementary Table 1).
Reasoning that decline of FANCD2 in exposed cells likely
reflected either enhanced proteolysis, suppression of translation,
or both, we tested both possibilities. We first treated cells in
advance of CSC treatment with a proteasome inhibitor (epoxo-
micin). Treatment had little or no effect on FANCD2 levels alone
and did not reverse CSC-induced suppression (Figure 5B). We also
quantified the effects of CSC on the degradation rate of FANCD2.
Using a dose of cycloheximide that inhibited global RNA
translation by 95% after 3h (data not shown), the half-life of
FANCD2 (approximately 8h) was not altered by cotreatment with
0.2% CSC (Figures 5C and D).
It is known that cigarette smoke inhibits global protein
translation in vitro and in vivo in the airway (Yeager, 1969;
Hamosh et al, 1979), but there is no known linkage of that general
effect with a specific mechanism of carcinogenesis. We confirmed
global translational effects of CSC by measuring differences in
[
35S]-methionine/cysteine incorporation after CSC treatment.
Within 2h of exposure, CSC significantly inhibited translation
(Figure 6A). To confirm that translation of FANCD2 mRNA was
suppressed, we measured [
35S]-methionine/cysteine incorporation
into FANCD2 protein by immunoprecipitation (Figure 6B).
Within 3h of exposure to CSC, [
35S]-methionine/cysteine FANCD2
levels were reduced by approximately 80% compared with
untreated controls. Therefore, global translation is suppressed
and FANCD2 mRNA is not exempt. That suppression of this
particular transcript is of relevance to carcinogenesis and CIN is
confirmed by the protective effect of ectopic FANCD2 expression
(Figures 2C–E).
To determine if neoplastic cells retained responsiveness to CSC,
we measured the effects of CSC on FANCD2 expression in
bronchogenic carcinoma cells (A549 and H292). Cigarette smoke
condensate suppressed FANCD2 in cancer cells (Figure 7A), but
these cells were significantly more resistant to CSC in survival
(Figure 7B) and apoptosis assays (Figure 7C) than were normal
airway epithelial cells. Thus, bronchogenic carcinoma cells (A549
and H292) do exhibit CSC-induced FANCD2 suppression, but have
become partially resistant to CSC.
DISCUSSION
We quantified native and monoubiquitinated FANCD2 in airway
epithelial cells to screen for dysfunction of the FA/BRCA pathway.
We found that CSC suppressed translation of FANCD2 mRNA,
reducing both forms of FANCD2 and sensitising epithelial cells of
the airway to DNA crosslinking agents. Linkage of the cytotoxic
effects of CSC with FANCD2 suppression was confirmed in murine
Fancd2-deficient cells, which were found to be sensitive to both
CSC-induced toxicity and chromosomal breakage. In gain-of-
function studies, overexpression of FANCD2, but not FANCC or
FANCG, in normal airway epithelial cells protected CSC-exposed
cells from undergoing apoptosis. Finally, CSC downregulated
FANCD2 in bronchogenic carcinoma cells, but these cells were
partially resistant to CSC-induced toxicity.
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Figure 5 Cigarette smoke condensate does not inhibit transcription of FANCD2 or degradation of FANCD2. (A) FANCD2 and PCNA mRNA levels after
exposure to 0.2% CSC for indicated times (means±s.d. from a representative experiment of two performed in triplicate) are shown. Values are relative to
controls (0h time point). (B) Immunoblots of HIT1-SVTEL cells treated where indicated with different concentrations of epoxomicin for 2h and then 0.2%
CSC for 24h are shown. (C) Immunoblot of HIT1-SVTEL cells treated with 0.2% CSC and/or 20mgml
 1 cycloheximide (CHX) for 16h is shown. (D)
FANCD2 measured densitometrically from three experiments of HIT1-SVTEL cells treated with 0.2% CSC and/or 20mgml
 1 CHX for indicated hours
(mean±s.d.) is shown. Solid and dashed lines represent cells treated with CHX alone or CHX and CSC, respectively.
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and CIN has been well established (Jemal et al, 2001; Masuda and
Takahashi, 2002), the molecular mechanisms by which cigarette
smoke induces chromosomal damage have not been well defined.
Here, we identify CSC-induced suppression of FANCD2 gene
expression as a novel mechanism of cigarette smoke-induced CIN
and demonstrate for the first time carcinogen-induced repression
of the FA/BRCA pathway. It is widely recognised that FA proteins
promote chromosomal stability, FA cells display both endogenous
and DNA crosslinker-induced CIN, and monoubiquitination of
FANCD2 plays key regulatory roles (reviewed in Bagby and
Alter, 2006). However, the precise biochemical mechanisms by
which these molecules control chromosomal stability have not
been delineated. Whether the role of the proteins is direct or
indirect is unclear. Several lines of evidence suggest FA proteins
are involved in DNA repair and recombination (Mathew, 2006),
including the identification of FANCD1 as BRCA2 (Howlett et al,
2002). More recently, two FA genes, FANCJ and FANCM, were
found to possess DNA helicase and/or endonuclease motifs
(Levitus et al, 2005; Litman et al, 2005; Meetei et al, 2005). Other
roles of FA proteins in preventing CIN have been suggested,
including prevention of oxidative damage induced by reactive
oxygen species or cytokine exposure (Pagano, 2000; Cumming
et al, 2001; Zhang et al, 2007).
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Figure 6 Cigarette smoke condensate inhibits FANCD2 translation. (A) Cigarette smoke condensate significantly inhibited [
35S] incorporation at 2h for
both concentrations (means±s.d. from three experiments performed in duplicate, P¼0.009, ANOVA). (B) Autoradiogram of immunoprecipitated [
35S]-
FANCD2 in indicated cells treated with or without CSC for 3h is shown. PD20/D2 and PD20 cells are positive and negative controls, respectively. FANCD2
expression was measured densitometrically and relative expression was calculated in CSC-treated HIT1-SVTEL cells by comparison with untreated cells (set
to 100%). Values represent the mean and standard deviation from three independent experiments. FANCD2 synthesis in HIT1-SVTEL cells was significantly
lower after CSC treatment (P¼0.005, t-test).
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Figure 7 Bronchogenic carcinoma cells are resistant to CSC-induced toxicity but not FANCD2 downregulation. (A) Immunoblots of bronchogenic
carcinoma cells (A549 and H292) treated for 8 and 24h with 0.2% CSC are shown. (B) Survival analyses of cells treated for 24h (means±s.d. from a
representative of three independently performed experiments in triplicate) with indicated concentrations of CSC are shown. Cancer lines A549 and H292
showed different responses to treatment with CSC than HIT1-SVTEL (P¼0.02, regression analyses). (C) Apoptotic responses in cells treated for 24h
(means±s.d. from a representative of two experiments performed in triplicate) with indicated concentrations of CSC are shown. (D) A proposed model of
CSC-induced CIN is shown. Exposure of cigarette smoke (CS) downregulates FANCD2 expression and induces apoptosis in a proportion of exposed cells.
Re-exposure to CS induces chromosomal damage due to decreased FANCD2 and facilitates selection of clones that may become resistance to the
apoptosis-inducing actions of CS.
Cigarette smoke suppresses FANCD2
LE Hays et al
1659
British Journal of Cancer (2008) 98(10), 1653–1661 & 2008 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sAnalysis of the Fanconi Anemia Transcriptome Consortium
Public Release (http://www.genesifter.net/web/hematology1a.html),
a publicly available gene expression array database comparing
normal and FA bone marrow RNA, reveals potential noncanonical
roles of FA proteins in mediating chromosomal stability.
Specifically, 2035 RNA transcripts are significantly decreased in
FA bone marrow compared with normal controls (0.75-fold or less
with a P-value of 0.05 corrected for multiple comparisons using
Benjamini and Hochberg method), and, of these transcripts, the
largest significant ontological categories include mitotic cell cycle,
spindle organisation and biogenesis, and several related categories
(see Supplementary Tables 2 and 3 for lists of individual
transcripts). Thus, FA proteins may mediate chromosomal
stability by regulating the expression of genes that stabilise the
mitotic machinery.
Cigarette smoke-induced inhibition of global protein synthesis has
been demonstrated by several groups in different tissues/cell types
(lung, alveolar macrophages, and liver), and in both in vitro and
in vivo animal models (Yeager, 1969; Garrett and Jackson, 1979;
Hamosh et al, 1979; Leffingwell and Low, 1979; Hellstern et al, 1990).
The mechanism of CSC-induced protein synthesis inhibition remains
enigmatic. Of relevance to the studies herein, the linkage of
translational suppression with suppression of specific proteins that
mediate CSC-induced toxicity and chromosomal damage has not
been previously reported. Here, we confirmed that CSC inhibited
global protein synthesis in vitro in our model system of lung
epithelial cells and identified downregulation of FANCD2, clearly
indicating that in vivo studies are warranted.
Because translation is globally suppressed, any single or
combination of proteins could theoretically contribute to CSC-
induced CIN. However, while we cannot rule out the possibility
that other downregulated proteins contribute to this response,
we did confirm directly the significance of FANCD2 in mediating
chromosomal stability by ectopically expressing FANCD2 in
epithelial cells and demonstrating a protective effect against
CSC-induced toxicity (Figure 2D). FANCD2 overexpression
also protected cells against MMC-induced sensitivity in CSC-
exposed cells (Figure 2C). Furthermore, CSC did not substantially
affect the expression of FA proteins FANCC and FANCG
(Figure 1E) and ectopic expression of these FA proteins did not
provide protective effects against CSC (Figure 3B). Thus, down-
regulation of FANCD2 appears to be a critical event in cigarette
smoke-induced CIN.
Fanconi anaemia cells are hypersensitive to a variety of
apoptotic cues (Rosselli, 1998) and oxidative stress (Pagano and
Youssoufian, 2003), and there is emerging evidence that for
neoplastic clones to evolve their progenitors must adapt by
inactivating precisely the apoptotic signalling pathways aberrantly
activated as a result of FA gene inactivation (Lensch et al, 1999).
Whether somatic events are adaptive or arise by selection of pre-
existing mutant clones is not yet known, but the process is likely
facilitated by the inherent genetic instability of FA cells. This
theoretical model of carcinogenesis is perfectly congruent with
observations here that CSC suppresses FANCD2 levels and, as a
consequence, induces both genetic instability and apoptosis.
Furthermore, we found that bronchogenic carcinoma cells were
still sensitive to CSC-induced FANCD2 downregulation and thus
CIN, but were at least in part resistant to CSC-induced apoptosis.
Owing to well-established variations in survival responses of in
vitro cell lines, we cannot conclusively demonstrate that cancer
cells are more resistant to CSC than nonneoplastic epithelial cells
of the airway. However, another group recently reported similar
results (Kode et al, 2006). In this study, three lung cancer cell lines,
only one of which was the same as used in our study (A549),
displayed less cytotoxicity in response to cigarette smoke extract
than primary small airway epithelial cells.
We, therefore, propose a model of the role of FANCD2
suppression in cigarette smoke-induced lung cancer (Figure 7D)
in which cigarette smoke suppresses FANCD2 in vivo, creating
recurring cycles of cytotoxicity and CIN. Suppression of FANCD2
translation renders cells more sensitive to clastogen/DNA-dama-
ging agents present in cigarette smoke upon re-exposure to
cigarette smoke. These responses likely create perfect conditions
for the selection of new clones that resist apoptotic cues including
those contained in cigarette smoke.
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